Homocysteine-Induced Endothelial Dysfunction

Area of Science:

• Cardiovascular Science
• Endothelial Biology
• Metabolic Pathways

Background:

• Hyperhomocysteinemia is a recognized independent risk factor for cardiovascular diseases, including atherosclerosis and ischemic heart attacks.
• Elevated homocysteine levels are linked to endothelial dysfunction, a condition affecting blood vessel health and function.

Purpose of the Study:

• To review the cellular pathways and biological processes underlying homocysteine-induced endothelial dysfunction.
• To emphasize the impact of homocysteine on endothelial-dependent vasodilation and nitric oxide bioavailability.

Main Methods:

• Review of existing literature on homocysteine, endothelial function, and nitric oxide metabolism.
• Discussion of mechanisms including nitric oxide synthase uncoupling, oxidative stress, and inflammation.
• Mention of flow-mediated dilation using ultrasound as a monitoring method for endothelial dysfunction.

Main Results:

• Elevated homocysteine reduces nitric oxide (NO) bioavailability through multiple pathways.
• Mechanisms include impaired NO synthesis, increased NO degradation by oxidative stress, and inhibition by asymmetric dimethylarginine.
• Endoplasmic reticulum stress, apoptosis, inflammation, and prothrombotic conditions also contribute to endothelial dysfunction.

Conclusions:

• Homocysteine-induced endothelial dysfunction is primarily mediated by impaired nitric oxide bioavailability.
• Understanding these mechanisms is crucial for comprehending the link between hyperhomocysteinemia and cardiovascular risk.
• Further research into these pathways can inform strategies for managing cardiovascular disease associated with elevated homocysteine.